Risks of cannabis are not always dramatic or immediate. They are subtle, cumulative and easy to rationalize – until they are ...

The move to reclassify cannabis from a Schedule I to a Schedule III drug could spark new studies into pain, aging and women's health, Dr. Staci Gruber tells GBH's All Things Considered.

The story everyone knows about the opioid epidemic goes like this: Big, bad Purdue Pharma aggressively marketed its potent ...

President Trump set the process in motion to ease federal restrictions on marijuana. But his order doesn't automatically ...